Literature DB >> 11826398

Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression.

Kimberley J Woodcroft1, Mikehl S Hafner, Raymond F Novak.   

Abstract

Diabetes has been reported to increase the expression of cytochrome P450 (CYP) 2E1 messenger RNA (mRNA) and protein several-fold, and enhanced expression has been associated with elevated ketone bodies. Primary cultured rat hepatocytes were used to explore ketone body and insulin regulation of CYP2E1 expression. Hydroxybutyrate and acetoacetate (AC), alone or in combination, either failed to affect or decreased CYP2E1 mRNA levels by up to 90% relative to untreated hepatocytes. Insulin produced a concentration-dependent decrease in CYP2E1 mRNA levels, and insulin receptor immunoprecipitation showed a correspondence between receptor phosphorylation and the decrease in CYP2E1 mRNA levels at physiologic levels of insulin. Phosphatase inhibitors decreased CYP2E1 mRNA levels by greater than 95%. The phosphatidylinositol 3-kinase (PI3-kinase) inhibitors wortmannin or LY294002 and rapamycin, an inhibitor of p70 S6 kinase phosphorylation, ameliorated the insulin-mediated decrease in CYP2E1 mRNA levels. Geldanamycin, which inhibits Src kinase, also abrogated the insulin-mediated decrease in CYP2E1 mRNA levels. In contrast, the protein kinase C (PKC) inhibitor bisindolylmaleimide, the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059, and the p38 mitogen-activated protein (MAP) kinase inhibitor SB202190 did not affect the insulin-mediated decrease in CYP2E1. CYP2E1 mRNA half-life decreased from approximately 48 hours in the absence of insulin to approximately 15 hours at 10 nmol/L insulin, and this decrease was prevented by wortmannin. The half-life of CYP2B mRNA was increased by insulin, whereas that of CYP3A was unaffected. Analysis of CYP2E1 gene transcription using heterogeneous nuclear RNA (hnRNA) showed that insulin suppressed CYP2E1 transcription. In conclusion, these data show involvement of transcriptional and posttranscriptional mechanisms in the insulin-mediated regulation of CYP2E1 and implicate PI3-kinase, p70 S6 kinase, and Src kinase in mediating these effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826398     DOI: 10.1053/jhep.2002.30691

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.

Authors:  Hermann M Bolt; Peter H Roos; Ricarda Thier
Journal:  Int Arch Occup Environ Health       Date:  2003-03-01       Impact factor: 3.015

2.  Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

Authors:  Dan Xu; Feng Li; Mian Zhang; Ji Zhang; Can Liu; Meng-yue Hu; Ze-yu Zhong; Ling-ling Jia; Da-wei Wang; Jie Wu; Li Liu; Xiao-dong Liu
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

3.  Regulatory sequence responsible for insulin destabilization of cytochrome P450 2B1 (CYP2B1) mRNA.

Authors:  Nhu-Traï Truong; Arlette Moncion; Robert Barouki; Philippe Beaune; Isabelle de Waziers
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 4.  Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.

Authors:  Steven D Lidofsky
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

5.  Alcohol steatosis and cytotoxicity: the role of cytochrome P4502E1 and autophagy.

Authors:  Defeng Wu; Xiaodong Wang; Richard Zhou; Lili Yang; Arthur I Cederbaum
Journal:  Free Radic Biol Med       Date:  2012-07-20       Impact factor: 7.376

Review 6.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

7.  Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats.

Authors:  Gökçe Kuzgun; Rahman Başaran; Ebru Arıoğlu İnan; Benay Can Eke
Journal:  J Diabetes Metab Disord       Date:  2020-08-24

8.  Expression of constitutive and inducible cytochrome P450 2E1 in rat brain.

Authors:  Sanjay Yadav; Alok Dhawan; Ram L Singh; Prahlad K Seth; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

9.  Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.

Authors:  Zaiqi Wang; Stephen D Hall; Juan F Maya; Lang Li; Ali Asghar; J C Gorski
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

10.  Global phosphoproteomics identifies a major role for AKT and 14-3-3 in regulating EDC3.

Authors:  Mark Larance; Alexander F Rowland; Kyle L Hoehn; David T Humphreys; Thomas Preiss; Michael Guilhaus; David E James
Journal:  Mol Cell Proteomics       Date:  2010-01-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.